<DOC>
	<DOCNO>NCT02071537</DOCNO>
	<brief_summary>The purpose research study test safety chloroquine combination carboplatin gemcitabine see effect ( good bad ) advance solid tumor . Also , research study increase dose chloroquine find high dose chloroquine give combination carboplatin gemcitabine without cause severe side effect .</brief_summary>
	<brief_title>Chloroquine Combination With Carboplatin/Gemcitabine Advanced Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Chloroquine diphosphate</mesh_term>
	<mesh_term>Chloroquine</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Histologically confirm diagnosis malignancy metastatic unresectable either standard curative measure exist longer effective carboplatin/gemcitabine consider reasonable treatment option whether first line acceptable approved combination therapy . Age &gt; 18 year age . Performance status less equal 2 ( Karnofsky &gt; 60 % ) Life expectancy great 3 month . Adequate labs Measurable disease Current treatment investigational agent . Patients untreated brain metastasis History allergic reaction attribute compound similar chemical biologic composition chloroquine agent use study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>